Fixed-dose combination

Results: 323



#Item
31PMH NPEP protocol dec 2012

PMH NPEP protocol dec 2012

Add to Reading List

Source URL: kidshealthwa.com

Language: English - Date: 2014-01-08 01:50:15
32Patient Information STRIBILD® (STRY-bild) (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate) Tablets Important: Ask your healthcare provider or pharmacist about medicines

Patient Information STRIBILD® (STRY-bild) (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate) Tablets Important: Ask your healthcare provider or pharmacist about medicines

Add to Reading List

Source URL: www.gilead.com

Language: English - Date: 2014-12-18 01:58:03
33HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA.  •

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. •

Add to Reading List

Source URL: www.gilead.com

Language: English - Date: 2014-09-16 17:54:34
34Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that

Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that

Add to Reading List

Source URL: www.scottishmedicines.org.uk

Language: English
35Schering-Plough / Medicine / Statins / Pharmacology / Ezetimibe / Lactams / Rosuvastatin / Simvastatin / Hypolipidemic agent / Chemistry / Organic chemistry / Merck

5.4 EZETIMIBE + ATORVASTATIN fixed dose combination tablets; 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg; Atozet®; Merck Sharp & Dohme (Australia) Pty Ltd.

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:14
36Organic chemistry / Fixed dose combination / Pharmacology / Bristol-Myers Squibb / Cyclopropanes / Fixed-dose combination / Emtricitabine/tenofovir/efavirenz / Tenofovir/emtricitabine / Abacavir / Gilead Sciences / Chemistry / Organofluorides

5.2 DOLUTEGRAVIR + ABACAVIR + LAMIVUDINE dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet, 30; Triumeq®; Viiv Healthcare Pty Ltd. Purpose of Application

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:14
37Public Summary Document – November 2014 PBAC Meeting  5.4 EZETIMIBE + ATORVASTATIN fixed dose combination tablets;

Public Summary Document – November 2014 PBAC Meeting 5.4 EZETIMIBE + ATORVASTATIN fixed dose combination tablets;

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:14
38Public Summary Document – November 2014 PBAC Meeting  5.2 DOLUTEGRAVIR + ABACAVIR + LAMIVUDINE dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg

Public Summary Document – November 2014 PBAC Meeting 5.2 DOLUTEGRAVIR + ABACAVIR + LAMIVUDINE dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:14
39•	  New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine clearance before initiating treatment with ATRIPLA. In patients at risk for renal dysfuncti

• New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine clearance before initiating treatment with ATRIPLA. In patients at risk for renal dysfuncti

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2015-01-26 14:47:21
40Gilead Sciences / Pharmacology / Non-nucleoside reverse transcriptase inhibitors / Organofluorides / Bristol-Myers Squibb / Reverse-transcriptase inhibitor / ATC code J05 / Emtricitabine / Tenofovir / Chemistry / Organic chemistry / Fixed dose combination

STATE OF TENNESSEE DEPARTMENT OF HEALTH Ryan White Part B Program HIV DRUG ASSISTANCE PROGRAM (HDAP) FORMULARY

Add to Reading List

Source URL: tn.gov

Language: English - Date: 2015-03-19 08:38:15